RT Journal
A1 Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC
T1 TReatment of atypical depression with cognitive therapy or phenelzine
JF Archives of General Psychiatry
JO Archives of General Psychiatry
YR 2000
FD November 1
VO 57
IS 11
SP 1084
OP 1085
DO 
UL http://dx.doi.org/
AB 
In our article,1 we reported results from a double-blind, placebo-controlled, randomized clinical trial comparing the efficacy of cognitive therapy and clinical management plus either phenelzine or pill placebo in reducing depressive symptoms of adult outpatients with DSM-III-R major depressive disorder with atypical features, which were assessed using the Atypical Depression Diagnostic Scale (ADDS) (J. W. Stewart, MD, written communication, October 20, 1988, and March 20, 1990). Using an intention-to-treat sample (N = 108) and a 21-item Hamilton Rating Scale for Depression (HRSD-212) score less than or equal to 9), the response rates after cognitive therapy (58%) and phenelzine (58%) were significantly greater than after pill placebo (28%).